Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash & Equivalents (2016 - 2025)

Mesa Laboratories' Cash & Equivalents history spans 16 years, with the latest figure at $29.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 6.05% year-over-year to $29.0 million; the TTM value through Dec 2025 reached $29.0 million, up 6.05%, while the annual FY2025 figure was $27.3 million, 3.17% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $29.0 million at Mesa Laboratories, up from $20.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $278.3 million in Q3 2021 and bottomed at $20.4 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $30.7 million (2023), against an average of $67.8 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 224.24% in 2021 before it tumbled 88.37% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $51.7 million in 2021, then crashed by 49.52% to $26.1 million in 2022, then grew by 8.13% to $28.2 million in 2023, then fell by 3.2% to $27.3 million in 2024, then grew by 6.05% to $29.0 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Cash & Equivalents are $29.0 million (Q4 2025), $20.4 million (Q3 2025), and $21.3 million (Q2 2025).